Webinar Recording: How to use TPMT and NUDT15 PGx to Reduce Thiopurines-related Adverse Reactions

Pharmacogenomics and Precision Medicine

Webinar Recording: How to use TPMT and NUDT15 PGx to Reduce Thiopurines-related Adverse Reactions

Presenters: Dr. Gunter Scharer

Recording Date: September 26, 2019

Contact Us

PGx at Boston Children's Hospital

Dr. Shannon Manzi discusses how TPMT and NUDT15 pharmacogenetics help Boston Children’s Hospital reduce thiopurines-related toxicity and overall cost of care.

Happy, healthy multigenerational family

Insight into TPMT and NUDT15

Learn more about how TPMT and NUDT15 variants lead to thiopurines-induced toxicity and how to use pharmacogentics to reduce the adverse reactions.

Resources

Learn more about pharmacogenetics using our educational resources.